Details

MIPS - Quality Measures - Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy

Quality Measures
Category QUALITY
Description Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) therapy
eMeasure ID
First Performance Year 2017
Last Performance Year
Metric Type Single Performance Rate
National Quality Strategy Domain ECC
Measure Type Process
eMeasure UUID
NQF eMeasure ID
NQF ID
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward American Gastroenterological Association
Submission Methods Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_275_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec

Back to List